Synthetic biology is transforming the development of human and animal therapeutics in ways unimaginable just a decade ago. The unreliable and costly process of discovery and development for new drugs is being replaced by a systems approach that includes genetic, molecular, and cellular engineering and computational biology.
Intrexon is leading this revolution. We apply the principles of science and engineering with our unique proprietary technologies to design and build new therapies for humans and animals. Our ability to design, build and regulate complex gene programs and cellular systems at commercial scale is unmatched in the industry. But we don’t do it alone. Through our Better DNA®
approach and Exclusive Channel Collaborations
, we are developing highly targeted applications and treatments, improving efficacy of existing treatments and accelerating production of higher quality bio-based solutions at lower cost.